Navigation Links
NewBridge Pharmaceuticals Announces Licensing of Pylera(R) for Middle East, Africa, Turkey & Caspian Region
Date:7/22/2009

DUBAI, United Arab Emirates and SAN FRANCISCO, July 22 /PRNewswire/ -- NewBridge Pharmaceuticals, a specialty pharmaceutical, biologics, and medical device company serving the Middle East, Africa, Turkey & Caspian regions, today announced that it has entered into an exclusive license and supply agreement with Axcan Pharma for Pylera(R), an innovative 3-in-1 capsule therapy for the eradication of Helicobacter pylori, a bacterium now recognized as being the main cause of gastric and duodenal ulcers. Pursuant to the agreement, NewBridge is entitled to obtain exclusive rights in certain markets where it obtains required regulatory approvals and launches the product. The product should be launched in Q4 2010.

Pylera(R), which was developed by Axcan over the last ten years, is a patented 3-in-1 capsule therapy. Each Pylera(R) capsule contains bismuth subcitrate potassium, metronidazole and tetracycline hydrochloride. Pylera(R) is clinically proven to be as effective as the most widely prescribed therapeutic regimen for the eradication of Helicobacter pylori (omeprazole, amoxicillin and clarithromycin) and has the potential to be used in a wide range of patients as a first-line therapy for the eradication of Helicobacter pylori based on its convenient 10-day treatment dosing regimen. Pylera(R) provides additional clinical benefit by improving patient compliance. Pylera(R) received FDA approval in September 2006 and was successfully launched in the United States in May 2007.

"In partnering with Axcan for the Pylera 3-in-1 capsule therapy for Helicobacter pylori eradication, NewBridge Pharmaceuticals advances further to become one of the key providers of innovative pharmaceutical care to the Middle East, Turkey, CIS and Africa," said Dr. Garrett Vygantas, CEO of NewBridge Pharmaceuticals. "NewBridge's strategy of providing world-cla
'/>"/>

SOURCE NewBridge Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Newbridge Securities Corporation Forms BioVentures Division
2. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
3. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
4. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
5. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
6. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
7. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
8. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
9. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
10. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
11. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... Aug. 26, 2014  ViveBio, LLC a leading ... stabilization and transportation, announced today that it has ... LLC (LPS) of Knoxville, Tennessee ... the United States . ViveST ... ambient temperature dried biological specimen transport systems.  The ...
(Date:8/26/2014)... Fla. , Aug. 26, 2014 ... under the symbol (NUUU) has two (2) wholly- ... Our two subsidiaries harness scientifically advanced technology to ... NUUU,s Renuell Int,l, Inc. is ... anti-aging skin care products that is made possible ...
(Date:8/26/2014)... Scranton, PA (PRWEB) August 26, 2014 ... San Jose, CA, which specializes in chemical process equipment, ... with Michigan State University’s Facility for Rare Isotope Beams ... ft. long precision cleaning line made with Vycom’s Flametec ... resonators, which are the essential parts of FRIB’s linear ...
(Date:8/26/2014)... WASHINGTON , Aug. 26, 2014 ... Next Generation Dx Summit; Moving Assays to ... "Targeted Detection and Monitoring of Cell Free Tumor ... the analytical component of its Precision Cancer Monitoring ... high clinical sensitivity for the detection of tumor ...
Breaking Biology Technology:ViveBio and Laboratory Procurement Services Sign Agreement for Distribution of the ViveST Line of Products 2Technology Applications International Corporation, Trading Symbol NUUU now trading on NASDAQ's Over the Counter Bulletin Board (OTC BB) 2Modutek Selects Vycom’s Flametec Materials for Michigan State University’s Superconductor Equipment 2Modutek Selects Vycom’s Flametec Materials for Michigan State University’s Superconductor Equipment 3Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 2Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 3Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 4
... , ,As the manufacturing sector struggles to recover ... may view a career in building things a bit ... goes on in todays factories, maybe theyd amend that ... and other modern staples of the manufacturing sector simply ...
... source of problem , ,Madison, WI- Over 2,200 computers ... latest e-mail virus last week. At the same time, it ... it was the recipient of a continuous large scale flood ... public Network Time Protocol (NTP) servers. NTP servers are used ...
... at the helm of several companies, Michael Flavin, CEO of ... Ill. across from Argonne National Laboratory ), sees a ... , ,Following a six-month preparation period, Flavin says hell ... financial adviser Legg Mason to raise about $30 ...
Cached Biology Technology:Manufacturing still viable career 2Manufacturing still viable career 3Flawed Routers Flood UW Server 2Flawed Routers Flood UW Server 3Advanced Life Sciences to Hit the Road For $30 Million in Funding 2Advanced Life Sciences to Hit the Road For $30 Million in Funding 3Advanced Life Sciences to Hit the Road For $30 Million in Funding 4
(Date:8/26/2014)... researchers at the University of Illinois at Urbana-Champaign ... design, paving the way for power-on-a-chip applications. ... microscopic scale that amplify light and produce ultra-narrowband ... of electrical and computer engineering (ECE) at Illinois. ... optical power on a chip containing both electronic ...
(Date:8/26/2014)... and the PETA International Science Consortium, LTD (PISC) scientists ... World Congress on Alternatives and Animal Use in the ... use of animals in research, testing and medical training, ... oversight systems. , At the conference, which is being ... PISC will present seven oral and poster presentations, including: ...
(Date:8/25/2014)... the US has experienced widespread adoption of robot-assisted ... recent years. The BJU International study ... expensive than traditional surgeries, their costs are decreasing ... robotic technologies in operations to remove the prostate. ... robotic-assisted radical prostatectomy (RARP) procedures for prostate cancer ...
Breaking Biology News(10 mins):Symphony of nanoplasmonic and optical resonators produces laser-like light emission 2US has seen widespread adoption of robot-assisted cancer surgery to remove the prostate 2
... a paper published today in Diabetologia , a team at ... the enzyme AMP kinase (AMPK) as key to the molecular mechanism ... spina bifida and some heart defects among babies born to women ... type 1 or type 2 -- work vigilantly to control their ...
... (PHB) is a thermoplastic polyester which occurs naturally in ... megaterium . Even though PHB is biodegradable and is ... traditionally too expensive to produce to replace petroleum-based plastics. ... Microbial Cell Factories describes an alternative method ...
... time, researchers have found a way to inject a precise ... living cell without a needle. The technique uses electricity ... and into a cell in a fraction of a second. ... University describe the technique in the online edition of the ...
Cached Biology News:Joslin study finds clue to birth defects in babies of mothers with diabetes 2Researchers do precise gene therapy without a needle 2Researchers do precise gene therapy without a needle 3
... Western blotting is a commonly used ... Typically, protein samples are electrophoresed on SDS-PAGE ... nitrocellulose or nylon, where they are probed ... technologies, which allow reuse of Southern and ...
... ProXPRESS 2D Proteomic Imaging System, Basic Package ... a Wide Dynamic Range: The ProXPRESS 2D ... in imaging system for both proteomic and ... provides unparalleled flexibility, enabling the use of ...
... Introducing our Regulatory Edition of Molecular Imaging ... systems for life science research and drug ... compliance with U.S. Food and Drug Administrations ... 11 Electronic Records; Electronic Signatures [21 CFR ...
... OPA1-01009, OPEP-01009 is a 16 amino acid (amino acids 3-18) ... (DFF). The sequence of this peptide is (amino to ... S - V - K - L - R - ... R - K(18). This peptide may be used ...
Biology Products: